How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Are Checkpoint Inhibitors the SOC in Frontline Hodgkin Lymphoma?

UChicago Medicine

B. Hu

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin's …

Insights from 2024 EHA Annual Meeting

M. Salamoon

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Update in the Understanding and Management of Lupus

ARTHROS

M. Petri

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

SOHO Turkey 2023: How I Treat Hodgkin Lymphoma

SOHO Turkey 2023

T. Toptas

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Lupus Medication Management Tips: How to Manage the Side Effects of …

The Lupus Foundation, Philadelphia Tri-State Chapter

A. Askanase

Hurdles on the Way to Disease Modification in Lupus

ARTHROS

M. Petri

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

When Not to Use Muscle Relaxants, How Frequent is Loneliness in RA/P…

RheumNow

J. Cush

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

SLE Faculty Panel: Q&A at RheumNow Live! 2024

RheumNow

D. Karp, J. Michelle Kahlenberg, A. Fava

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush